Medical News

Moreover Technologies - Pharma industry news - 30 of 25640 retur...
Moreover Technologies - Real-time news and blogs from thousands of sources

Beware Teeth Whitening Scams! - Sponsored Link
Ad - Discover A Mum's Secret Trick That Gave Her A Celebrity Smile For 3.35!
KIKA Clinical Solutions Announces Veracity 3.8, Newest Version of its Advance...
- announced the availability of Veracity 3.8, the latest version of its innovative EDC solution. KIKA is the leading provider of advanced EDC solutions for for the pharmaceutical, biotechnology and medical device markets. KIKA CEO Linda Beneze commented,
Biovail Targets Paddock Over Aplenzin ANDA
Extract not available.
UPDATE: FDA Reviews Osteoporosis Drugs For Fracture Risk
(Updates with additional information from FDA and adds new study data starting in the third paragraph.) WASHINGTON -(Dow Jones)- The Food and Drug Administration said Wednesday it's conducting a safety review of certain bone-building drugs like Fosamax
Cellzome, GSK Sign $45M Screening Pact
The companies will use Cellzome's Episphere chemical proteomics technology to identify candidates for anti-inflammatory drugs. If certain milestones are met, Cellzome could potentially receive ?475 million.
Biosearch Seeks to Enter IVD Market with Expanded Roche License
Biosearch Technologies has taken an important step toward entering the in vitro diagnostics market by expanding its license with Roche Molecular Systems in the area of nucleic acid amplification technologies, the company said this week. Under the new
UPDATE: FDA Reviews Osteoporosis Drugs For Fracture Risk
(Updates with additional information from FDA and adds new study data starting in the third paragraph.) Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The Food and Drug Administration said Wednesday it's conducting a safety review of certain
Nabi Biopharmaceuticals logs revenue from Glaxo sale
Nabi Biopharmaceuticals realized $10.5 million in revenue in its fiscal fourth quarter after collecting development payments from GlaxoSmithKline PLC for its PentaStaph drug. Nabi sold the drug to GSK in November for an expected total of $46 million,
FDA: more changes coming on drug safety
FDA Commissioner Margaret Hamburg told lawmakers at a U.S. House of Representatives budget panel she was "moving forward with some strategies to enhance how we address drug safety." Hamburg declined to give details. But after the hearing, she told
Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New ...
Extract not available.
Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New ...
PR Newswire FORT LEE, N.J., March 10 FORT LEE, N.J., March 10 /PRNewswire/ -- Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), today announced that the U.S. Food and Drug Administration (FDA)
GSK to slash prices to appeal to lower income group in India
The World' second largest pharmaceutical company GlaxoSmithKline (GSK) has announced that it will slash its retail prices for various medicines in India. The strategy behind this price cut in its drugs is to furnish to the lower-income group in the
FDA: more changes coming on drug safety (Reuters)
WASHINGTON (Reuters) Recent new powers have helped the combat contaminated medications, counterfeit pills and other safety woes, but more work is needed to address lingering concerns about drug risks, FDA officials said on Wednesday. FDA Commissioner
Allergan wins FDA approval for spasticity drug
(Datamonitor via COMTEX) Allergan, a multi-specialty healthcare company, has reported that the FDA has approved Botox for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity. According to
Taro Pharmaceutical wins FDA approval for fluorouracil cream
(Datamonitor via COMTEX) Taro Pharmaceutical Industries has received the FDA's approval of its abbreviated new drug application for fluorouracil topical cream USP, 5%, fluorouracil cream. According to Taro Pharmaceutical Industries, its fluorouracil